Biotechnology

Covaris launches novel viral RNA extraction kits for swab sample collection devices

- Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs - Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Massachusetts, Feb. 18, 2020 /PRNewswire/ -- Covaris, Inc. tod...

2020-02-18 23:00 2498

Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism and Outcome-based Care Models

High adoption of annuity-based reimbursement programs by payers and therapy manufacturers will unlock the potential of gene therapies, finds Frost & Sullivan SANTA CLARA, California, Feb. 18, 2020 /PRNewswire/ -- Despite rising trade tension and a sluggish economic outlook for 2020, the global h...

2020-02-18 20:03 3296

WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologics (stock code: 2269.HK) and Shanghai Hile Bio-technology (stock code: 603718.SH) announced that it has entered into a strategic partners...

2020-02-18 18:18 4520

Seegene launches KFDA Approved COVID-19 Assay

SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronavirus (COIVD-19) Real-time PCR assay for the Emergency Use, following the rec...

2020-02-18 08:00 4121

Global Cord Blood Corporation Provides Update on Impact of Coronavirus

HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 ...

2020-02-14 19:30 13001

Eirgenix Receives Approval from Japan's PMDA

TAIPEI, Feb. 14, 2020 /PRNewswire/ -- EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanese pharmaceutical company and has since fulfilled all the regulatory requirements necessary to complete the manufacturing site transfer. The ...

2020-02-14 15:14 2855

Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases

HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the progress achieved by the Group in the research and development of drugs for treati...

2020-02-14 10:35 7528

George Clinical Names James Cheong Chief Executive Officer

SYDNEY, Feb. 13, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has namedJames Cheong to the role of Chief Executive Officer. Cheong was hired as Chief Operating Officer at the beginning of 2019 and has overseen substantial growth of the bu...

2020-02-13 01:00 1862

Sirtex Medical announces collaboration with MIM Software Inc.

Partnership advances innovation and increases precision of liver-directed oncology therapies for patients WOBURN, Massachusetts, Feb. 12, 2020 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced a collaboration with MIM Software Inc., a lead...

2020-02-12 22:00 1713

WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday

SHANGHAI, Feb. 12, 2020 /PRNewswire/ -- With the end of the extended Lunar New Year holiday, WuXi AppTec sites inChina have resumed operations today, with the exception of our site inWuhan, which will reopen when local regulations permit. These steps are being taken in compliance with disease con...

2020-02-12 20:00 1437

IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs

MENLO PARK, California, Feb. 12, 2020 /PRNewswire/ -- IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in im...

2020-02-12 03:25 2336

Genomenon Commended by Frost & Sullivan for Advancing Clinical Genomics Interpretation and Personalized Medicine with Its Mastermind Platform

The company's content-rich genomic database platform and AI-driven processing help mitigate early-stage genomic translational research challenges SANTA CLARA, California, Feb. 11, 2020 /PRNewswire/ -- Based on its recent analysis of the global clinical genomics interpretation market, Frost & Sul...

2020-02-11 22:00 1316

Carbiotix Launches Second Generation Diagnostic Platform

STOCKHOLM, Feb. 11, 2020 /PRNewswire/ -- Carbiotix (publ) ("Carbiotix") announces today that the company has launched its second generation diagnostic platform for gut health based on Next Generation Sequencing (NGS). The company will now offer a NGS test with three samples as a standard and at a...

2020-02-11 16:11 857

Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020

PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced  the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...

2020-02-10 21:42 5143

Origin Agritech Updates GMO Corn Seed Research and Commercialization Strategies

BEIJING, Feb. 10, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today updates the progress of biotech research programs and strategies for the commercialization of GMO corn seeds and traits.   As the ...

2020-02-10 21:00 4911

Nanoform Establishes US Subsidiary

HELSINKI, Feb. 10, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has established NanoformUSA Inc., a wholly owned subsidiary in the US. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization™ te...

2020-02-10 15:26 868

Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement

MELBOURNE, Australia and SAN FRANCISCO, Feb. 7, 2020 /PRNewswire/ -- Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) has received notification from the Listing Qualifications Department of NASDAQ advising the Company that it is currently non-compliant with NASDAQ's requirement that listed se...

2020-02-07 21:00 11685

Human Breast Milk Breakthrough by TurtleTree Labs

SINGAPORE, Feb. 7, 2020 /PRNewswire/ -- TurtleTree Labs sets to showcase the world's first human breast milk using cell-based technology at theirApril 21, 2020 Future of Clean Milk launch. Coming off from a successful funding round, the team has brought on world class scientists likeJonathan Loh ...

2020-02-07 15:00 1998

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 12756

Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director

HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...

2020-02-06 19:30 7093